BiomedicalPublications

The Pharmacogenomics Journal

Springer Nature·United Kingdom·ISSN 1470-269X

Subscription or hybridMedicine

The Pharmacogenomics Journal is published by Springer Nature as a subscription journal (ISSN 1470-269X). The list article processing charge is $4,890. Its OpenAlex h-index is 110. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.

Cost to publish

$4,890

Open-access article processing charge, list price.

Checked · How we source APCs

Time to publication

—

Not reported to DOAJ.

h-index

110

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

3.7

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in The Pharmacogenomics Journal is listed at $4,890. The publisher also lists 3,890 EUR, 3,090 GBP. No waiver policy is recorded in our sources, which does not mean none exists. Ask.

What this journal has charged over time

List price for an open-access article in The Pharmacogenomics Journal, as recorded by OpenAlex for each year. The fee has risen 30% since 2019, from $3,760 to $4,890.

$0$2.4k$4.9k2019: $3,76020192020: $3,86020202021: $3,86020212022: $4,19020222023: $4,39020232024: $4,59020242025: $4,8902025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelNot reported
LicenceNot reported
Author keeps copyrightNot reported
Plagiarism screeningNot reported
Editorial boardNot linked in DOAJ
LanguagesNot reported

Verification checks

3 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsNot listed. Many legitimate subscription journals are not in DOAJ, so this alone means little.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredNo declared model found in DOAJ.
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects The Pharmacogenomics Journal publishes most, derived from the topics assigned to its indexed articles.

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsGenetic Associations and EpidemiologyPharmacological Effects and Toxicity StudiesColorectal Cancer Treatments and StudiesReceptor Mechanisms and SignalingComputational Drug Discovery MethodsAcute Lymphoblastic Leukemia researchNeurotransmitter Receptor Influence on BehaviorGenomics and Rare Diseases

Publication record

Indexed articles1,578
Total citations63,422
i10-index1,163
Most recent indexed article2026
All ISSNs1470-269X, 1473-1150

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.